Receptor-type tyrosine-protein kinase FLT3 — Drug Target
2 drugs
2 marketed
All drugs that target Receptor-type tyrosine-protein kinase FLT3 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Kinase Inhibitor
Marketed (2)
- Ofev · Boehringer Ingelheim · Kinase Inhibitor · Oncology
Ofev works by blocking enzymes that promote fibrosis and tumor growth. - Tavalisse · Rigel Pharms · Immunology
Tavalisse works by blocking the activity of the FLT3 enzyme, which is involved in the production of platelets.